Michael D. Clayman
2014
In 2014, Michael D. Clayman earned a total compensation of $2.9M as President, CEO and Co-Founder at Flexion Therapeutics.
Compensation breakdown
| Bonus | $225,102 |
|---|---|
| Option Awards | $2,149,718 |
| Salary | $450,204 |
| Other | $32,357 |
| Total | $2,857,381 |
Clayman received $2.1M in option awards, accounting for 75% of the total pay in 2014.
Clayman also received $225.1K in bonus, $450.2K in salary and $32.4K in other compensation.
Rankings
In 2014, Michael D. Clayman's compensation ranked 3,187th out of 13,032 executives tracked by ExecPay. In other words, Clayman earned more than 75.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,187 out of 13,032 | 76th |
Division Manufacturing | 1,133 out of 4,965 | 77th |
Major group Chemicals And Allied Products | 363 out of 1,690 | 79th |
Industry group Drugs | 285 out of 1,369 | 79th |
Industry Pharmaceutical Preparations | 233 out of 1,042 | 78th |
Source: SEC filing on April 26, 2016.
Clayman's colleagues
We found two more compensation records of executives who worked with Michael D. Clayman at Flexion Therapeutics in 2014.